<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">With the growing focus of the US health care system on the meaningful use of electronic medical records, one of the practical applications is expanding biosurveillance and preparedness capabilities, such as surveillance of influenza severity and associated risk factors during seasonal epidemics and pandemics [
 <xref ref-type="bibr" rid="CR18">18</xref>, 
 <xref ref-type="bibr" rid="CR22">22</xref>]. Traditional influenza surveillance data are based on laboratory testing of a limited number of samples, case reporting by participating health care providers, hospital-based primary data, and deaths reported by statistics offices [
 <xref ref-type="bibr" rid="CR24">24</xref>]. Data extracted from electronic medical records can enrich reporting of risk factors for disease severity or clinical diagnoses, even in the absence of laboratory testing, and augment the traditional surveillance. In addition, monitoring patients EHRs may enable detection of disease outbreaks for which no laboratory diagnostics were requested including emerging pathogens and biothreat events [
 <xref ref-type="bibr" rid="CR25">25</xref>].
</p>
